Health and Human Services Secretary Robert F. Kennedy Jr. fired the chair and vice chair of the U.S. Preventive Services Task Force earlier this month, the latest move in a broader shake-up of the federal panel that decides which screenings and preventive treatments Americans can receive at no out-of-pocket cost.
Letters dated May 11 informed Dr. John Wong, the task force chair and a professor of medicine at Tufts University School of Medicine, and Dr. Esa Davis, the vice chair and a professor at the University of Maryland School of Medicine, that their positions were terminated. An HHS official confirmed the removals, as Reuters first reported after reviewing the letters Wednesday.
Kennedy described the terminations as "administrative in nature." His correspondence stated that HHS aims to implement "standard operating procedures" at the task force and protect its long-term credibility. The framing suggests the secretary views the removals not as a political purge but as housekeeping, a reset of an advisory body that some conservatives have long criticized as ideologically tilted.
The firings did not happen in a vacuum. The Preventive Services Task Force, which typically carries 16 volunteer members, has been effectively dormant. Kennedy canceled its regularly scheduled meetings, and the panel last convened over a year ago.
Five volunteers' terms expired in December. No replacements have been named. With Wong and Davis now gone, the body that shapes billions of dollars in insurance coverage decisions sits hollowed out, unable to update screening guidelines for cancers, heart disease, and other conditions even if it wanted to.
Medical experts say the standstill has delayed guideline updates. For patients, that means recommendations on everything from mammograms to diabetes screenings remain frozen in place while the bureaucratic machinery sits idle.
HHS has signaled it does not intend to leave the panel empty forever. Last month, a division of the department announced it was seeking clinicians and researchers to be nominated to the task force. The call covered specialties "including but not limited to" cardiology, oncology, obstetrics and gynecology, pediatrics, family medicine, and health economics. Applications remain open through May 23.
The health secretary selects task force members without Senate confirmation, a design that gives Kennedy wide latitude to reshape the panel's composition and, potentially, its philosophical orientation. That authority is not new; every HHS secretary has held it. But Kennedy is the first to wield it while simultaneously clearing the existing leadership and halting the panel's work.
The administration's broader effort to reshape public health leadership extends well beyond this single panel. Trump recently named Dr. Erica Schwartz as his pick to lead the CDC, part of a wider push to install leaders more aligned with the Make America Healthy Again agenda.
The task force has drawn fire from some conservatives who view it as too left-leaning. Its recommendations carry enormous weight: under the Affordable Care Act, insurers must cover preventive services the panel rates as beneficial, with no cost-sharing for patients. That gives a small group of volunteer physicians outsized influence over what health plans must pay for, and, by extension, what premiums look like.
Critics argue the panel has at times strayed beyond evidence into advocacy. Defenders counter that it has operated for decades as an independent, science-driven body insulated from political pressure. Last July, a coalition of 104 health organizations, including the American Medical Association and the American Academy of Pediatrics, sent a letter to Congressional health committees urging lawmakers "to protect the integrity" of the task force.
That letter landed months before Kennedy's most aggressive moves against the panel. It reflected anxiety across the medical establishment that the incoming administration might do exactly what has now happened.
Kennedy's tenure at HHS has been marked by a series of high-profile internal clashes. His chief HHS spokesperson recently resigned over a dispute involving flavored vapes, underscoring the policy tensions running through the department.
The practical stakes are not abstract. The Preventive Services Task Force issues letter grades, A, B, C, D, on screenings and interventions. An A or B rating triggers a coverage mandate under federal law. Without a functioning panel, no new ratings can be issued. Existing recommendations stay in place, but they age. Science moves. Guidelines that were current three years ago may no longer reflect the best available evidence.
For the millions of Americans who rely on no-cost preventive care, the freeze means uncertainty. New screening tools, updated age thresholds, emerging evidence on risk factors, none of it gets formally evaluated until the task force is reconstituted and meeting again.
Meanwhile, the broader confirmation battles over Trump's health nominees continue to generate friction. The surgeon general nominee recently had to clarify his stance on the measles vaccine after a contentious hearing, a reminder that every health appointment now carries political voltage.
Kennedy's letters frame the overhaul as a credibility play, protecting the task force's reputation by imposing standard procedures. That argument has surface appeal. Any institution benefits from clear rules and fresh leadership.
But credibility is hard to build while a panel sits empty. The task force has not met in over a year. Seven of its typical 16 seats are now vacant or terminated. No timeline has been given for when a reconstituted panel might begin work. The application window closes May 23, but naming members and scheduling meetings are separate steps with no announced deadlines.
The Make America Healthy Again movement has already begun reshaping how the public thinks about federal health institutions. A former HHS adviser was recently tapped by Steak 'n Shake to serve as its "Chief MAHA Officer," a sign that the administration's health branding has reached well beyond Washington.
Whether Kennedy's reset of the Preventive Services Task Force produces a sharper, more accountable panel, or simply a prolonged gap in guidance, depends entirely on what comes next. The firings are the easy part. Rebuilding is where credibility is earned or lost.
Several important details remain unclear. HHS has not said who will lead the task force in the interim, or when nominees might be announced. The full contents of Kennedy's May 11 letters have not been released publicly. And while the application window for new members closes in days, no process or timeline for final selections has been disclosed.
Legal challenges to various Trump administration health policies have also drawn fresh judicial scrutiny, raising the possibility that courts could eventually weigh in on executive authority over advisory panels if opponents choose to litigate.
Reforming a stale institution is fair game. Leaving it gutted and dark for a year, then asking the public to trust that the fix is coming, is a different matter entirely.
